MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Epidemiology of Huntington’s Disease in Latin America: A Systematic Review and Meta-analysis.

    A. Medina Escobar, T. Pringsheim, S. Gautreau, J. Rivera-Duarte, G. Amorelli, M. Cornejo-Olivas, M. Rossi (Moncton, Canada)

    Objective: To calculate the pooled prevalence of Huntington's Disease in Latin America. Background: Latin America has played a crucial role in advancing our understanding of…
  • 2024 International Congress

    Indentifying Key Features for Predicting Clinical Status in Huntington’s Disease Patients Using Raw Speech Samples: a Lightweight Machine Learning Approach

    T. Le Ludec, C. Le Moine, A-C. Bachoud-Lévi, R. Massart (Creteil, France)

    Objective: This study aims to identify key features relevant for predicting the clinical status of patients with Huntington’s Disease (HD) using machine learning techniques applied…
  • 2024 International Congress

    Mapping the Efficacy Landscape: A Network Meta-Analysis of Pharmacological Interventions in Huntington’s Disease

    A. Bhonsale, V. Suresh, B. Javed, M. Shamim, T. Dave, V. Ghosh, S. Sen, M. Muneer, D. Dey, M. Jayan, B. Dhakal, S. Vasipalli, R. Jena (Nagpur, India)

    Objective: To evaluate and compare the efficacy of pharmacological interventions for Huntington's Disease through a network meta-analysis, identifying the most effective treatments. Background: Huntington’s Disease…
  • 2024 International Congress

    Pitolisant as adjunct therapy for refractory restless legs syndrome

    W. Ondo (Houston, USA)

    Objective: Determine the efficacy and tolerability of pitolisant for adjunct therapy in patients with refractory restless legs syndrome (RLS) Background: RLS treatments include iron, dopaminergics,…
  • 2024 International Congress

    A Review of the Genetic Spectrum of Hereditary Spastic Paraplegias in the Middle East and North Africa Region

    M. Salari, S. Soleimani, F. Hojjati Pour (Tehran, Islamic Republic of Iran)

    Objective: To systematically review existing literature and collect data on Hereditary Spastic Paraplegias(HSP) in the Middle East and North Africa(MENA), aiming to assess the prevalence…
  • 2024 International Congress

    How Common is Essential Tremor in Germany? A Real-World Claims Data Analysis

    JS. Becktepe, S. Müller, T. Wilke, E. Zhuleku, K. Appiah, K. Mcdonald, N. Dzimitrowicz, J. Marshall, J. Sabater, LM. Barbato, TA. Saifee (Kiel, Germany)

    Objective: To estimate the prevalence and incidence of essential tremor (ET) stratified by age and sex, using insurance claims data from a large representative [1,2]…
  • 2024 International Congress

    A Phase 2b Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of OnabotulinumtoxinA for the Treatment of Upper Limb Essential Tremor: ELATE Trial

    K. Patterson, N. Alibhai, D. Khosla, L. James (North Chicago, USA)

    Objective: Here, we present the eligibility criteria and study design of ELATE, a Phase 2b clinical trial evaluating the safety and efficacy of onabotA compared…
  • 2024 International Congress

    Genetic Analysis of UK Kindreds with Familial Tremor in The Global Parkinson’s Genetics Progam (GP2)

    S. Jasaityte, R. Real, E. Stafford, R. Tilney, M. Fenn, A. Singleton, C. Blauwendraat, L. Lange, C. Klein, ZH. Fang, H. Morris, GP2. Genetics Program (London, United Kingdom)

    Objective: To gain a better understanding of the genetic basis of familial tremor syndromes. Background: The genetic basis of tremor is poorly understood and familial…
  • 2024 International Congress

    Movement Disorders In Children With Monoamine Neurotransmitter Disorders

    M. Ben Hafsa, H. Benrhouma, T. Ben Younes, H. Klaa, A. Zioudi, Z. Miladi, I. Ben Youssef-Turki, I. Kraoua (Tunis, Tunisia)

    Objective: To describe clinical, para-clinical, therapeutic and evolutionary characteristics of movement disorders (MD) and oculogyric crises (OC) in children with monoamine neurotransmitter disorders (MND) Background:…
  • 2024 International Congress

    Parkinsonism in combined Fragile X and XYY Syndromes: A Case Report

    M. Carta, B. Balint (Zurich, Switzerland)

    Objective: We describe an unusual case of parkinsonism in a 45-year-old male with Fragile X syndrome and XYY syndrome. Background: Fragile X syndrome (FXS) is…
  • « Previous Page
  • 1
  • …
  • 30
  • 31
  • 32
  • 33
  • 34
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley